354 related articles for article (PubMed ID: 1708742)
1. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
Tomihira M
Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
[TBL] [Abstract][Full Text] [Related]
2. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease.
Suou T; Yamada S; Hosho K; Yoshikawa N; Kawasaki H
Hepatology; 1996 May; 23(5):1154-8. PubMed ID: 8621148
[TBL] [Abstract][Full Text] [Related]
4. Plasma collagen-binding vitronectin activated by heparin and dextran sulfate in chronic liver disease.
Yamada S; Kobayashi J; Kawasaki H
Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):315-24. PubMed ID: 9387191
[TBL] [Abstract][Full Text] [Related]
5. Vitronectin in the cirrhotic liver: an immunomarker of mature fibrosis.
Koukoulis GK; Shen J; Virtanen I; Gould VE
Hum Pathol; 2001 Dec; 32(12):1356-62. PubMed ID: 11774169
[TBL] [Abstract][Full Text] [Related]
6. [Plasma fibronectin in chronic liver diseases].
Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
[TBL] [Abstract][Full Text] [Related]
7. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
Simon K; Zalewska M; Gładysz A; Rotter K; Piszko P; Głowacki A
Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358
[TBL] [Abstract][Full Text] [Related]
8. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance].
Xie J; OuYang K; Su T
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):93-6. PubMed ID: 10681810
[TBL] [Abstract][Full Text] [Related]
9. The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells.
Underwood PA; Bennett FA
Exp Cell Res; 1993 Apr; 205(2):311-9. PubMed ID: 7683271
[TBL] [Abstract][Full Text] [Related]
10. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP
Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625
[TBL] [Abstract][Full Text] [Related]
11. Detection of fibronectin receptor in sera: its clinical significance as a parameter of hepatic fibrosis.
Yamauchi M; Nakajima H; Ohata M; Hirakawa J; Mizuhara Y; Nakahara M; Kimura K; Fujisawa K; Kameda H
Hepatology; 1991 Aug; 14(2):244-50. PubMed ID: 1830562
[TBL] [Abstract][Full Text] [Related]
12. Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene.
Steele JG; Johnson G; Underwood PA
J Biomed Mater Res; 1992 Jul; 26(7):861-84. PubMed ID: 1376730
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
15. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy.
Casaroli Marano RP; Vilaró S
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2791-803. PubMed ID: 7514582
[TBL] [Abstract][Full Text] [Related]
16. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
18. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
19. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
20. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
Huang CW; Bai L; Cai JJ; Guo W; Lan L
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
